Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 13/20 | 0.55 |
| ▸ | NPC1 | O15118 | 10/20 | 0.55 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17288680 | 0.90 | ALDH1A1 (0.52) | RAB9ANPC1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL15931944 | 0.90 | MAPT (0.50) | RAB9ANPC1ADRB2MAPTALDH1A1 | |
| SCHEMBL15931831 | 0.90 | MAPT (0.64) | RAB9ANPC1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL15932182 | 0.89 | MAPT (0.63) | RAB9ANPC1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL15931959 | 0.87 | ADRB2 (0.58) | RAB9ANPC1ADRB2MAPTALDH1A1 | |
| SCHEMBL17298747 | 0.87 | RAB9A (0.63) | RAB9ANPC1KMT2A | |
| SCHEMBL15931997 | 0.86 | KMT2A (0.56) | RAB9ANPC1ADRB2MAPTALDH1A1 | |
| SCHEMBL17298745 | 0.86 | RAB9A (0.54) | RAB9ANPC1MAPTLMNAL3MBTL1 | |
| SCHEMBL15931958 | 0.85 | MAPT (0.53) | RAB9ANPC1MAPTALDH1A1LMNA | |
| SCHEMBL17298742 | 0.85 | RAB9A (0.58) | RAB9ANPC1ADRB2MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9814235-B2 | Method for controlling arthropod pest | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-14 | — | — | US | disclosed |
| US-20150344466-A1 | METHOD FOR CONTROLLING ARTHROPOD PEST | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344466-A1 | METHOD FOR CONTROLLING ARTHROPOD PEST | H1-0, H1-3, H1-2 | RAB9A 400/4885NPC1 3630/4885ADRB2 1204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.